A long-established British industrial name is heading towards a potential exit from the London Stock Exchange, but the headline needs some context. Bodycote, a specialist engineering business founded in 1923, has agreed to a proposed £1.85 billion takeover by US private equity firm Veritas Capital, which would ultimately remove its shares from public trading. (Reuters)
The development also raises a wider question for UK investors: what actually happens to your shares when a listed company is taken private?
What’s actually true
Bodycote provides heat treatment, metal joining, hot isostatic pressing and coating services used across industries including aerospace, defence, automotive and energy. It was founded almost 103 years ago, although its current London Stock Exchange listing dates from 1972. (Bodycote Heat Treatment)
That distinction matters. The business has a history stretching back more than a century, but it has not been listed on the London market for the whole of that period.
The immediate reason for the potential departure is a takeover. On September 1, Bodycote’s board announced it had agreed to a recommended cash acquisition by a company controlled by Veritas Capital. The agreed offer is worth 940p per Bodycote share, including the stated offer value and dividend arrangements. (London South East)
A rival bidder, CVC Advisers, was also considering an offer but confirmed on September 28 that it would not proceed. That leaves Veritas’ agreed transaction as the route currently being pursued. (Investegate)
How this connects to UK shareholders
For an ordinary shareholder, a takeover is different from a company simply deciding to move its listing overseas.
Under the proposed scheme of arrangement, Bodycote shareholders are being asked to approve the transaction at meetings scheduled for 21 October 2026. If the required approvals and other conditions are satisfied, the transaction is expected to become effective in the first quarter of 2027. (London South East)
If it completes, Bodycote intends to cancel its listing on the Official List and its admission to trading on the London Stock Exchange. The shares would therefore cease to trade publicly and shareholders would receive the cash consideration specified under the scheme. (London South East)
This is why investors should not automatically interpret a delisting as meaning a company is failing. In Bodycote’s case, the proposed departure is a consequence of an agreed acquisition that would transfer ownership from public shareholders to private investors.
Common misconceptions about a London delisting
“The company is going bust.”
Not necessarily. A company can leave the stock market because it has been acquired, because its owners want private ownership, or for other strategic reasons.
“My shares simply disappear.”
In a completed cash takeover structured like Bodycote’s proposed scheme, shareholders receive the consideration set out in the transaction documents. The exact process and timing depend on the scheme becoming effective.
“Every London-listed company leaving is moving to America.”
Again, no. Bodycote’s proposed transaction is a takeover by a US private equity firm, not a plan to transfer Bodycote’s shares to a US stock exchange. The company would become privately owned if the acquisition completes.
What to do next
If you own Bodycote shares, the most important step is to read the company’s scheme document and shareholder communications, rather than relying on headlines or social-media commentary. The document sets out the offer terms, conditions, voting requirements and timetable. (London South East)
Shareholders should also check how their broker will handle the transaction and consider whether they need independent financial or tax advice, particularly if the cash payment could affect their personal tax position.
For investors who do not own Bodycote, the bigger lesson is to distinguish between a takeover, a delisting and a change of primary listing. They can have very different consequences for shareholders.
The key takeaway
Bodycote’s potential departure from London is primarily about its proposed acquisition by Veritas Capital, rather than the metal-processing business simply abandoning the UK market. The company has a history dating back to 1923, but its London listing began in 1972. (Bodycote Heat Treatment)
The proposed deal still requires shareholder and court approval, so the outcome and timetable can change. Investors should therefore check the latest company announcement and official scheme documentation before taking action. (London South East)
